Published in Stroke on October 30, 2008
Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol (2009) 6.02
Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med (2010) 2.23
Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study. Lancet Neurol (2012) 1.79
Biology of vascular malformations of the brain. Stroke (2009) 1.70
Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology (2011) 1.62
Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol (2009) 1.47
Outcome after surgical or conservative management of cerebral cavernous malformations. Neurology (2014) 1.47
Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations. Genet Med (2014) 0.98
Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation. Cerebrovasc Dis (2013) 0.90
Vascular permeability in cerebral cavernous malformations. J Cereb Blood Flow Metab (2015) 0.82
Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity. Cerebrovasc Dis (2014) 0.81
Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1. Free Radic Biol Med (2016) 0.80
Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations. AJNR Am J Neuroradiol (2016) 0.79
Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain disease. J Neurosci Methods (2016) 0.76
From cavern-dwellers to cavernoma science: towards a new philosophy of cerebral cavernous malformations. Stroke (2008) 0.75
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations. Stroke (2016) 0.75
A novel CCM2 variant in a family with non-progressive cognitive complaints and cerebral microbleeds. Am J Med Genet B Neuropsychiatr Genet (2016) 0.75
Higher Rate of Intracerebral Hemorrhage in Hispanic Patients with Cerebral Cavernous Malformation. J Vasc Interv Neurol (2015) 0.75
Clinical Management of Cavernous Malformations. Curr Cardiol Rep (2017) 0.75
Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet (2003) 2.58
Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 2.50
Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med (2010) 2.23
Genomics of human intracranial aneurysm wall. Stroke (2009) 2.06
Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol (2007) 2.01
SWAN MRI revealing multiple microhemorrhages secondary to septic emboli from mucormycosis. Neurology (2012) 1.97
Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke (2011) 1.91
Biology of vascular malformations of the brain. Stroke (2009) 1.70
Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke (2005) 1.70
Brainstem cavernous malformations: 1390 surgical cases from the literature. World Neurosurg (2012) 1.58
Accuracy and reproducibility of manual and semiautomated quantification of MS lesions by MRI. J Magn Reson Imaging (2003) 1.45
A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum Mol Genet (2010) 1.39
What's the problem with generic antiepileptic drugs?: a call to action. Neurology (2007) 1.30
Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance. Neurosurgery (2004) 1.29
Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus. Hum Mutat (2006) 1.24
Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery (2011) 1.20
Deletions in CCM2 are a common cause of cerebral cavernous malformations. Am J Hum Genet (2006) 1.19
Intracranial cavernous angioma: a practical review of clinical and biological aspects. Surg Neurol (2005) 1.18
Neuroendovascular interventions for intracranial posterior circulation disease via the transradial approach: technical case report. Neurosurgery (2005) 1.17
ATP1A3 mutations in infants: a new rapid-onset dystonia-Parkinsonism phenotype characterized by motor delay and ataxia. Dev Med Child Neurol (2012) 1.14
Differential gene expression in human cerebrovascular malformations. Neurosurgery (2003) 1.13
Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models. Neurosurgery (2008) 1.12
Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery (2009) 1.10
Spectrum of genotype and clinical manifestations in cerebral cavernous malformations. Neurosurgery (2006) 1.05
IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice. Cancer Invest (2010) 1.02
Extending the Reach of Early Intervention Training for Practitioners: A Preliminary Investigation of an Online Curriculum for Teaching Behavioral Intervention Knowledge in Autism to Families and Service Providers. Infants Young Child (2010) 1.01
Oligoclonal immune response in cerebral cavernous malformations. Laboratory investigation. J Neurosurg (2007) 1.01
Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic review. Neurosurg Focus (2010) 0.98
Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts. Neurogenetics (2007) 0.94
Immune response in human cerebral cavernous malformations. Stroke (2009) 0.94
Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype. FEBS J (2010) 0.92
Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping. Invest Radiol (2014) 0.91
Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution. Neurosurg Focus (2010) 0.91
Advanced magnetic resonance imaging of cerebral cavernous malformations: part I. High-field imaging of excised human lesions. Neurosurgery (2008) 0.91
Cavernous malformations of the basal ganglia and thalamus. Neurosurgery (2009) 0.91
Variations in structural protein expression and endothelial cell proliferation in relation to clinical manifestations of cerebral cavernous malformations. Neurosurgery (2005) 0.91
Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation. Cerebrovasc Dis (2013) 0.90
Concepts and hypotheses: inflammatory hypothesis in the pathogenesis of cerebral cavernous malformations. Neurosurgery (2007) 0.89
External ventricular drainage for intraventricular hemorrhage. Curr Neurol Neurosci Rep (2012) 0.89
Mutational analysis of 206 families with cavernous malformations. J Neurosurg (2003) 0.89
Fenestration of supraclinoid internal carotid artery and associated aneurysm: embryogenesis, recognition, and management. World Neurosurg (2011) 0.89
Brainstem cavernous malformations. Neurosurgery (2009) 0.87
Cerebral cavernous malformations: clinical insights from genetic studies. Neurosurg Focus (2006) 0.86
Spontaneous intracerebral and intraventricular hemorrhage: advances in minimally invasive surgery and thrombolytic evacuation, and lessons learned in recent trials. Neurosurgery (2014) 0.86
Further study of CD31 protein and messenger ribonucleic acid expression in human cerebral vascular malformations. Neurosurgery (2002) 0.85
Clinical characterization and blepharoptosis surgery outcomes in Hispanic New Mexicans with oculopharyngeal muscular dystrophy. Ophthal Plast Reconstr Surg (2009) 0.85
Ventricular catheter location and the clearance of intraventricular hemorrhage. Neurosurgery (2012) 0.84
Outcome predictors and spectrum of treatment eligibility with prospective protocolized management of intracerebral hemorrhage. Neurosurgery (2009) 0.83
The illness representations of multiple sclerosis and their relations to outcome. Br J Health Psychol (2003) 0.83
Thrombolytic evacuation of intracerebral and intraventricular hemorrhage. Curr Cardiol Rep (2012) 0.82
Spine patient outcomes research trial. J Neurosurg (2003) 0.82
Childhood febrile status epilepticus: chicken or egg? Does it matter? Neurology (2012) 0.82
Multiple spinal cavernous malformations with atypical phenotype after prior irradiation: case report. Neurosurgery (2004) 0.82
Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity. Cerebrovasc Dis (2014) 0.81
Swallow characteristics in patients with oculopharyngeal muscular dystrophy. J Speech Lang Hear Res (2010) 0.81
Retrograde suction decompression of giant paraclinoid aneurysms using a No. 7 French balloon-containing guide catheter. Technical note. J Neurosurg (2006) 0.80
Elucidating the formation of 6-deoxyheptose: biochemical characterization of the GDP-D-glycero-d-manno-heptose C6 dehydratase, DmhA, and its associated C4 reductase, DmhB. Biochemistry (2009) 0.80
Drainage efficiency with dual versus single catheters in severe intraventricular hemorrhage. Neurocrit Care (2012) 0.80
Corrigendum: Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature (2016) 0.79
Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designs. Clin Pharmacokinet (2013) 0.78
Radiosurgery for angiographically occult vascular malformations. Neurosurg Focus (2009) 0.78
Sensitivity of patients with familial cerebral cavernous malformations to therapeutic radiation. J Med Imaging Radiat Oncol (2015) 0.78
Unraveling RYR1 mutations and muscle biopsies. Neurology (2008) 0.77
Current updates in perioperative management of intracerebral hemorrhage. Neurol Clin (2006) 0.77
How frequently should we follow small asymptomatic intracranial aneurysms? Stroke (2006) 0.77
Cavernous malformations. J Neurosurg (2011) 0.76
Advances in open neurovascular surgery 2007. Stroke (2008) 0.75
A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations. Genet Med (2011) 0.75
A "pseudo-cavernoma" - an encapsulated hematoma of the choroid plexus. J Clin Neurosci (2011) 0.75
From mutant mice to "vascular permeability therapy" in cavernous angiomas? Neurosurgery (2009) 0.75
Current updates in perioperative management of intracerebral hemorrhage. Neurosurg Clin N Am (2008) 0.75
External ventricular drain-related infections: dilemmas of definitions, generalisability and associations versus causations. J Neurol Neurosurg Psychiatry (2017) 0.75
Temporary and permanent occlusion of cervical and cerebral arteries. Neurosurg Clin N Am (2005) 0.75
Simple Genes and Complex Diseases. Neurosurgery (2004) 0.75
Update on current registries and trials of carotid artery angioplasty and stent placement. Neurosurg Focus (2005) 0.75
Fatal "hypertensive" intracerebral hemorrhage associated with a cerebral cavernous angioma: case report. Acta Neurochir (Wien) (2010) 0.75
Muscle weakness and speech in oculopharyngeal muscular dystrophy. J Speech Lang Hear Res (2015) 0.75
Stochastic kinematic modeling and feature extraction for gait analysis. IEEE Trans Image Process (2003) 0.75
Surrogate measures of outcome in clinical trials: clues worth examining? Neurosurgery (2008) 0.75
'Standards and guidelines for standards and guidelines': intracranial dural arteriovenous shunts as a paradigm. J Neurointerv Surg (2016) 0.75
Extreme spindles: a distinctive EEG pattern in Mycoplasma pneumoniae encephalitis. Neurology (2005) 0.75
Author response. Neurology (2015) 0.75
Neurosurgery and big science. Neurosurgery (2008) 0.75
Ruptured superior cerebellar artery aneurysm in a child with bilateral fibromuscular hyperplasia of the renal arteries: case report and review of the literature. J Neurosurg (2005) 0.75
Chemistry of life: green fluorescent protein and the 2008 Nobel Prize in Chemistry. Neurosurgery (2008) 0.75
Engineering the ideal bypass graft. Neurosurgery (2008) 0.75
Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases. Cerebrovasc Dis (2017) 0.75
Episteme and the marvelous continuum in neurosurgical science. Neurosurgery (2009) 0.75
What genes can teach us about human cerebrovascular malformations. Clin Neurosurg (2004) 0.75
Hemorrhagic stroke: introduction. Stroke (2013) 0.75
Clinical reasoning: cerebral cavernous malformations. Neurology (2009) 0.75